Medication Adherence among Psychotic Patients before Admission to Inpatient Treatment

Psychiatric Services

Volumn 55, Issue 2, 2004, Pages 174-179

  Rittmannsberger, Hans ^a   Pachinger, Thomas ^a   Keppelmüller, Peter ^a   Wancata, Johannes ^b  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CHLORPROMAZINE; NEUROLEPTIC AGENT; STABILIZING AGENT;

ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREDICTION; PSYCHIATRIST; PSYCHOSIS; SELF REPORT;

ADULT; ANTIPSYCHOTIC AGENTS; AUSTRIA; FEMALE; HOSPITALIZATION; HUMANS; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PROGNOSIS; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF ASSESSMENT (PSYCHOLOGY);

EID: 0842288343     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.55.2.174     Document Type: Article

References (48)

1. Gilbert PL, Harris MJ, McAdams LA, et al: Neuroleptic withdrawal in schizophrenic patients: a review of the literature. Archives of General Psychiatry 52:173-188, 1995
2. Cramer JA, Rosenheck R: Compliance with medication regimens for mental and physical disorders. Psychiatric Services 49:196-201, 1998
3. Powsner S, Spitzer R: Sex, lies, and medical compliance. Lancet 361:2003-2004, 2003
4. Carpenter WT, Strauss JS, Bartko JJ: Flexible system for the diagnosis of schizophrenia: report from the WHO international pilot study of schizophrenia. Science 182:1275-1278, 1973
5. Bartko G, Herczeg I, Zador G: Clinical symptomatology and drug compliance in schizophrenic patients. Acta Psychiatrica Scandinavica 78:74-76, 1988
6. Ghaemi SN, Pope HG: Lack of insight in psychotic and affective disorders: a review of empirical studies. Harvard Review of Psychiatry 2:22-33, 1994
7. McEvoy JP, Freter S, Everett C, et al: Insight and the clinical outcome of schizophrenic patients. Journal of Nervous and Mental Disease 177:48-51, 1989
8. McEvoy JP: The relationship between insight in psychosis and compliance with medication, in Insight in Psychosis. Edited by Amador XF, David AS. Oxford, England, Oxford University Press, 1998
9. Olfson M, Mechanic D, Hansell S, et al: Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services 51:216-222, 2000
10. Schwartz RC, Cohen BN, Grubaugh A: Does insight affect long-term inpatient treatment outcome in chronic schizophrenia? Comprehensive Psychiatry 38:283-288, 1997
11. Trauer T, Sacks T: The relationship between insight and medication adherence in severely mentally ill clients treated in the community. Acta Psychiatrica Scandinavica 102:211-216, 2000
12. Lacro JP, Dunn LB, Dolder CR, et al: Prevalence and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 63:892-909, 2002
13. Lysaker P, Bell M, Milstein R, et al: Insight and psychosocial treatment compliance in schizophrenia. Psychiatry 57:307-315, 1994
14. Babiker IE: Noncompliance in schizophrenia. Psychiatric Developments 186:329-337, 1986
15. Bebbington PE: The content and context of compliance. International Clinical Psychopharmacology 9(suppl 5):41-50, 1995
16. Marder SR, Mebane A, Chien C, et al: A comparison of patients who refuse and consent to neuroleptic treatment. American Journal of Psychiatry 140:470-472, 1983
17. Dekker FW, Dielemann FE, Kaptein AA, et al: Compliance with pulmonary medication in general practice. European Respiration Journal 6:886-890, 1993
18. Graber AL, Davidson P, Brown A, et al: Dropout and relapse during diabetes care. Diabetic Care 15:1477-1483, 1992
19. Horne R, Weinman J: Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research 47:555-567, 1999
20. Horowitz RI: Treatment adherence and risk of death after myocardial infarction. Lancet 336:542-545, 1999
21. Dolder CR, Lacro JP, Dunn LB, et al: Antipsychotic medication adherence: is there a difference between typical and atypical agents? American Journal of Psychiatry 159:103-108, 2002
22. Patel NC, Dorson PG, Edwards N, et al: One-year rehospitalization rates of patients discharged on atypical versus conventional antipsychotics. Psychiatric Services 53:891-893, 2002
23. Weiden PJ, Zygmunt A: Medication noncompliance in schizophrenia: I. assessment. Journal of Practical Psychiatry and Behavioral Health 3:106-110, 1997
24. Casper ES, Regan JR: Reasons for admission among six profile subgroups of recidivists of inpatient services. Canadian Journal of Psychiatry 38:657-661, 1993
25. Pristach CA, Smith CM: Medication compliance and substance abuse among schizophrenic patients. Hospital and Community Psychiatry 41:1345-1348, 1990
26. Donohoe G, Owens N, O'Donell C, et al: Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis. European Psychiatry 16:293-298, 2001.
27. CGI: Clinical Global Impression, in Manual for the ECDEU Assessment Battery, 2nd rev. Edited by Guy W, Benato R. Bethesda, Md, National Institute Mental Health, 1970
28. Diagnostic and Statistical Manual of Mental Disorders 4th ed, Text Revision. Washington, DC, American Psychiatric Association, 2000
29. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13:261-276, 1987
30. Lehman AF, Steinwachs DM: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin 24:1-10, 1998
31. Practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry 154(suppl 4):1-63, 1997
32. Statistical Package for IBM-PC. Chicago, SPSS Inc, 1990
33. Fleischhacker WW, Meise U, Günther V, et al: Compliance with antipsychotic drug treatment: influence of side effects. Acta Psychiatrica Scandinavica Supplement 382:11-15, 1994
34. Kwon J, Collins A, Christenson B: Medication compliance in patients with schizophrenia taking oral antipsychotics. International Journal of Psychopharmacology 3 (suppl 1):124-125, 2000
35. Buchanan A: A two-year prospective study of treatment compliance in patients with sehizophrenia. Psychological Medicine 22:787-797, 1992
36. Bartko G, Maylath E, Herczeg I: Comparative study of schizophrenic patients relapsed on and off medication. Psychiatry Research 22:221-227, 1987
37. McEvoy JP, Apperson LJ, Appelbaum PS, et al: Insight in schizophrenia: its relationship to acute psychopathology. Journal of Nervous and Mental Disease 177:43-47, 1989
38. McEvoy JP, Howe AC, Hogarty GE: Differences in the nature of relapse and subsequent inpatient course between medication-compliant and noncompliant schizophrenic patients. Journal of Nervous and Mental Disease 172:412-416, 1984
39. Svarstad BL, Shireman TI, Sweeney JK: Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatric Services 52:805-811, 2001
40. Weiden PJ, Dixon L, Frances A, et al: Neuroleptic noncompliance in schizophrenia, in Advances in Neuropsychiatry and Psychopharmacology: Vol I. Schizophrenia Research. Edited by Tamminga CA, Schulz SC. New York, Raven, 1991
41. Young JL, Zonana HV, Shepler L: Medication noncompliance in schizophrenia: codification and update. Bulletin of the American Academy of Psychiatry and the Law 14:105-122, 1986
42. Remington G, Shammi CN, Sethna R, et al: Antipsychotic dosing patterns for schizophrenia in three treatment settings. Psychiatric Services 52:96-98, 2001
43. McEvoy JP, Hogarty GE, Steingard S: Optimal dose of neuroleptic in acute schizophrenia: a controlled study of the neuroleptic threshold and higher haloperidol dose. Archives of General Psychiatry 48:739-745, 1991
44. Stone CK, Garver DL, Griffith J, et al: Further evidence of a dose-response threshold for haloperidol in psychosis. American Journal of Psychiatry 152:1210-1212, 1995
45. Hornung WP, Klingberg S, Feldmann R, et al: Collaboration with drug treatment by patients with and without psychoeducational training: results of a 1-year follow-up. Acta Psychiatrica Scandinavica 97:213-219, 1998
46. Haynes RB, McKibbon A, Kanani R: Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 348:383-386, 1996
47. Robinson D, Woerner MG, Alvir JM, et al: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 56:241-247, 1999
48. Weiden PJ, Olfson M: Cost of relapse in schizophrenia. Schizophrenia Bulletin 21:419-429, 1995